Table of Contents

Chapter 1 Overview of Nuclear Medicine

• 1.1 Definition of Nuclear Medicine in This Report
• 1.2 Commercial Types of Nuclear Medicine
  • 1.2.1 Tc-99
  • 1.2.2 I-123/131
  • 1.2.3 In-111
  • 1.2.4 Xe-133
  • 1.2.5 Th-201
  • 1.2.6 Ga-67
  • 1.2.7 Others
• 1.3 Downstream Application of Nuclear Medicine
  • 1.3.1 Diagnostic
  • 1.3.2 Therapeutic
• 1.4 Development History of Nuclear Medicine
• 1.5 Market Status and Trend of Nuclear Medicine 2016-2026
  • 1.5.1 Global Nuclear Medicine Market Status and Trend 2016-2026
  • 1.5.2 Regional Nuclear Medicine Market Status and Trend 2016-2026

Chapter 2 Global Market Status and Forecast by Regions

• 2.1 Market Development of Nuclear Medicine 2016-2021
• 2.2 Production Market of Nuclear Medicine by Regions
  • 2.2.1 Production Volume of Nuclear Medicine by Regions
  • 2.2.2 Production Value of Nuclear Medicine by Regions
• 2.3 Demand Market of Nuclear Medicine by Regions
• 2.4 Production and Demand Status of Nuclear Medicine by Regions
  • 2.4.1 Production and Demand Status of Nuclear Medicine by Regions 2016-2021
  • 2.4.2 Import and Export Status of Nuclear Medicine by Regions 2016-2021

Chapter 3 Global Market Status and Forecast by Types

• 3.1 Production Volume of Nuclear Medicine by Types
• 3.2 Production Value of Nuclear Medicine by Types
• 3.3 Market Forecast of Nuclear Medicine by Types

Chapter 4 Global Market Status and Forecast by Downstream Industry

• 4.1 Demand Volume of Nuclear Medicine by Downstream Industry
• 4.2 Market Forecast of Nuclear Medicine by Downstream Industry

Chapter 5 Market Driving Factor Analysis of Nuclear Medicine

• 5.1 Global Economy Situation and Trend Overview
• 5.2 Nuclear Medicine Downstream Industry Situation and Trend Overview

Chapter 6 Nuclear Medicine Market Competition Status by Major Manufacturers

• 6.1 Production Volume of Nuclear Medicine by Major Manufacturers
• 6.2 Production Value of Nuclear Medicine by Major Manufacturers
• 6.3 Basic Information of Nuclear Medicine by Major Manufacturers
  • 6.3.1 Headquarters Location and Established Time of Nuclear Medicine Major Manufacturer
  • 6.3.2 Employees and Revenue Level of Nuclear Medicine Major Manufacturer
• 6.4 Market Competition News and Trend
  • 6.4.1 Merger, Consolidation or Acquisition News
  • 6.4.2 Investment or Disinvestment News
  • 6.4.3 New Product Development and Launch

Chapter 7 Nuclear Medicine Major Manufacturers Introduction and Market Data

• 7.1 GE Healthcare
  • 7.1.1 Company profile
  • 7.1.2 Representative Nuclear Medicine Product
  • 7.1.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of GE Healthcare
• 7.2 Bracco Imaging
  • 7.2.1 Company profile
  • 7.2.2 Representative Nuclear Medicine Product
  • 7.2.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Bracco Imaging
• 7.3 Mallinckrodt
  • 7.3.1 Company profile
  • 7.3.2 Representative Nuclear Medicine Product
  • 7.3.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Mallinckrodt
• 7.4 Lantheus Medical Imaging
  • 7.4.1 Company profile
  • 7.4.2 Representative Nuclear Medicine Product
  • 7.4.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Lantheus Medical Imaging
• 7.5 Bayer
  • 7.5.1 Company profile
  • 7.5.2 Representative Nuclear Medicine Product
  • 7.5.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Bayer
• 7.6 Triad Isotopes
  • 7.6.1 Company profile
  • 7.6.2 Representative Nuclear Medicine Product
  • 7.6.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Triad Isotopes
• 7.7 Nordion
  • 7.7.1 Company profile
  • 7.7.2 Representative Nuclear Medicine Product
  • 7.7.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Nordion
• 7.8 Jubilant Pharma
  • 7.8.1 Company profile
  • 7.8.2 Representative Nuclear Medicine Product
  • 7.8.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Jubilant Pharma
• 7.9 Eli Lilly
  • 7.9.1 Company profile
  • 7.9.2 Representative Nuclear Medicine Product
  • 7.9.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Eli Lilly
• 7.10 SIEMENS
  • 7.10.1 Company profile
  • 7.10.2 Representative Nuclear Medicine Product
  • 7.10.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of SIEMENS
• 7.11 China Isotope & Radiation
  • 7.11.1 Company profile
  • 7.11.2 Representative Nuclear Medicine Product
  • 7.11.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of China Isotope & Radiation
• 7.12 Dongcheng
  • 7.12.1 Company profile
  • 7.12.2 Representative Nuclear Medicine Product
  • 7.12.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Dongcheng

Chapter 8 Upstream and Downstream Market Analysis of Nuclear Medicine

• 8.1 Industry Chain of Nuclear Medicine
• 8.2 Upstream Market and Representative Companies Analysis
• 8.3 Downstream Market and Representative Companies Analysis

Chapter 9 Cost and Gross Margin Analysis of Nuclear Medicine

• 9.1 Cost Structure Analysis of Nuclear Medicine
• 9.2 Raw Materials Cost Analysis of Nuclear Medicine
• 9.3 Labor Cost Analysis of Nuclear Medicine
• 9.4 Manufacturing Expenses Analysis of Nuclear Medicine

Chapter 10 Marketing Status Analysis of Nuclear Medicine

• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
  • 10.1.3 Marketing Channel Development Trend
• 10.2 Market Positioning
  • 10.2.1 Pricing Strategy
  • 10.2.2 Brand Strategy
  • 10.2.3 Target Client
• 10.3 Distributors/Traders List

Chapter 11 Report Conclusion

Chapter 12 Research Methodology and Reference

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources

Report Summary

Nuclear Medicine-Global Market Status and Trend Report 2016-2026 offers a comprehensive analysis on Nuclear Medicine industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Regional Market Size of Nuclear Medicine 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Nuclear Medicine worldwide, with company and product introduction, position in the Nuclear Medicine market
Market status and development trend of Nuclear Medicine by types and applications
Cost and profit status of Nuclear Medicine, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Nuclear Medicine market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Nuclear Medicine industry.

The report segments the global Nuclear Medicine market as:

Global Nuclear Medicine Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America
Europe
China
Japan
Rest APAC
Latin America

Global Nuclear Medicine Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Others

Global Nuclear Medicine Market: Application Segment Analysis (Consumption Volume and Market Share 2016-2026; Downstream Customers and Market Analysis)
Diagnostic
Therapeutic

Global Nuclear Medicine Market: Manufacturers Segment Analysis (Company and Product introduction, Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin):
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.